Cross-Sector entity
RadNet is the most frequent co-covered peer, appearing in 3 of the 3 tracked stories. The clearest coverage concentration is health-it: 1 of 3 stories, with the rest divided among 2 other categories. The tracked stories average 11 original sources each.
3 verified stories tracked
Last mentioned: Mar 3, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
RadNet is the most frequent co-covered peer, appearing in 3 of the 3 tracked stories. The clearest coverage concentration is health-it: 1 of 3 stories, with the rest divided among 2 other categories. The tracked stories average 11 original sources each. Senseonics appears in 3 tracked Cross-Sector stories from March 3, 2026.
Computed from the 3 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Senseonics. Shared-story counts are live from our verified record — not editorial picks.
A wave of Q4 2025 earnings reports across the industrial tech, health-tech, and marketplace sectors reveals a decisive shift from aggressive expansion to operational leverage. Led by Plug Power’s dramatic gross margin recovery, these companies are prioritizing unit economics and AI integration to reach positive EBITDA in 2026.
UroGen Pharma and Senseonics reported strong Q4 2025 results, driven by the successful commercial launches of Zasturi and Eversense 365. Both companies are navigating critical transitions—UroGen through new reimbursement codes and Senseonics by assuming full commercial control—positioning them for significant revenue scaling in 2026.
Healthcare technology and medical device leaders reported strong Q4 2025 results, characterized by aggressive AI acquisitions and successful transitions to direct commercial models. These shifts, led by RadNet and Senseonics, signal a maturing market for digital health platforms and long-term implantable technologies.
